Although corticosteroids have been used in the treatment of bronchial asthma for over 20 years (Carryer et al., 1950) , little is yet known with any certainty of the possible modes of action of corticosteroids or even of the precise site where they act in this condition. The time course of response to oral prednisolone and to intravenous hydrocortisone in chronic bronchial asthma has only recently been worked out (Ellul-Micallef, Borthwick, and McHardy, 1972; 1974) . Various time intervals, mostly based on clinical impressions, ranging from two hours (Cope, 1972) to 48 hours (Herxheimer, 1966) had previously been suggested.
It has been found that a statistically significant improvement (P<0 001) in the peak expiratory flow rate (PEFR) occurred two hours after 40 mg of prednisolone acetate were given orally in a single dose in a group of patients with chronic bronchial asthma. The maximum change in pulmonary function variables measured occurred nine hours after the drug had been given, and these changes ceased to be statistically significant at 36 hours. When 200 mg of hydrocortisone sodium succinate were injected intravenously the mean change in PEFR was significantly increased (P<0-05) one hour after the injection, the peak effect being attained in five hours. The mean change in PEFR was no longer significant 12 hours after hydrocortisone had been administered; the maximum change in PEFR following oral 312 prednisolone was 57%+8-5 and that due to intravenous hydrocortisone 51%+-48-0 of the initial pre-treatment values (Ellul-Micallef et al., 1972; 1974) .
This difference in the time course of the two corticosteroids was thought to be due mainly to two causes-to the different routes of administration used and to the fact that the two drugs are known to be metabolized at different rates. Table. Their airway obstruction had failed to respond to bronchodilator drugs, and they were finding it increasingly difficult to cope with their work but were reasonably comfortable in bed. They were admitted to hospital to determine whether their condition could be reversed by corticosteroid therapy. None of the patients had received corticosteroids before. No other drugs were given besides the test doses of corticosteroids, and as far as can be ascertained none had been receiving drugs capable of interfering with corticosteroid metabolism prior to their admission to hospital (Jubiz et al., 1970; Brooks et al., 1972) . (Wright and McKerrow, 1959) . The forced expiratory time was measured by placing a stethoscope on the posterior chest wall well above the diaphragm while the patient performed a forced expiration from a position of maximum inspiration and timing the procedure with a stopwatch from the first expiratory sound to the last (Rosenblatt and Stein, 1962) . The best of three successive, technically acceptable attempts was chosen (Freedman and Prowse, 1966 ). Statistical significance was tested in all instances by means of Student's t test (Snedecor and Cochran, 1971) .
RESULTS
All the patients were screened for respiratory tract infection, all having three sputum specimens negative on culture for ordinary pathogens and sputum which was macroscopically mucoid. The radiographic examination of the chest showed some evidence of hyperinflation but was otherwise normal, as was the electrocardiogram. There was no clinical nor biochemical evidence of hepatic or renal dysfunction. Six patients (Nos. 3, 4, 5, 8, 9 and 10) were extrinsic asthmatics, having blood and sputum eosinophilia and showing positive skin reactions to a wide variety of allergens.
No significant day to day or diurnal variation was observed nor could any response to the placebo injections be demonstrated within either individuals or the group as a whole, although minor fluctuations in the different variables measured could be observed during the placebo days. These fluctuations were not however significantly different from the immediate pre-treatment values. The results obtained following the injection of prednisolone have therefore been compared with those measurements obtained immediately before drug administration. In order to reduce the effect of individual variation all measurements were expressed as a percentage of the pre-treatment value.
The injection of prednisolone produced consistent changes in each patient in FEV, FVC, PEFR, and FET at the time of their first measurement, one hour after drug administration. This increase was statistically significant for the group as a whole (P<0-001; P<0-05; P<0-001; P<0'025). The peak effect occurred at eight hours (Figures 1-4 ) and the changes were still significant after 30 hours. The pre-treatment range of FET was 6-0-11-5 sec, with a mean of 8 2 sec+ 1 6 sec. Forced expiratory time correlated well with FEV, (r=087), FVC (r=0-82), and PEFR (r=0-86).
DISCUSSION
The time course of intravenous prednisolone appears to be very similar to that of oral prednisolone in the chronic asthmatic patients studied. (Schedl, 1965) . Thus triamcinolone, which is a very poorly absorbed compound, seems to be well enough absorbed from the small intestine to be active in the clinical situation. It appears likely that in these patients it is the longer persistence in the plasma of free unconjugated prednisolone which accounts for its longer activity.
In normal subjects prednisolone has a plasma half-life of about 240 minutes, while hydrocortisone has one of between 80 and 100 minutes (Peterson, 1959) . Collins et al. (1970) failed to find any statistically significant difference in the handling of intravenous hydrocortisone between normal subjects and asthmatic patients. It would appear that oral prednisolone is very rapidly absorbed in patients with chronic bronchial asthma just as it is in normal subjects. It appears that the response to corticosteroids varies with the severity of the asthmatic condition (unpublished data). The time course of response to corticosteroids reported in this study was obtained in chronic bronchial asthmatics with a stable degree of airway obstruction and may not apply to the acute state. 
